MedPath

Non Invasive Optical Imaging of WBC Count

Not Applicable
Completed
Conditions
Hematologic Malignancy
Interventions
Device: AM4113-N5UT Dino-Lite
Registration Number
NCT02512666
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This research study is looking at a small device that measures white blood cell (WBC) counts by being placed against the finger nail for participants who are undergoing stem cell transplantation at Massachusetts General Hospital or have a hematologic malignancy and are being seen as an outpatient.

Detailed Description

The objective of this study is to obtain data that would support the use of a method to obtain WBC counts from images of small blood vessels called capillaries. These would be obtained by pressing a small device on the surface of participants' finger nails to look through the nail. These images will be obtained using a portable microscope called the Dino-Lite Digital Microscope.

Having a non-invasive way to quickly measure WBC counts could be useful for a variety of healthcare applications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Patients with lymphoid malignancies or plasma cell dyscrasias who are admitted to the Massachusetts General Hospital to undergo autologous stem cell transplantation or are seen in the outpatient clinic
  • Age ≥ 18 years
  • Ability to understand and the willingness to sign a written informed consent document.
  • Patients must have WBC ≥ 3000 / µl and ANC ≥ 1500 / µl at admission or their last clinical visit to be enrolled.
Exclusion Criteria
  • History of allergic reactions attributed to compounds of similar chemical or biologic composition of baby oil.
  • Myelodysplasia
  • Skin phototype < 4 in the Fitzpatrick scale.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Non-Invasive ImagingAM4113-N5UT Dino-LiteCommercial portable optical microscope (AM4113-N5UT Dino-Lite ) which will be employed during the study for a pre determined time of non-invasive imaging of the nailfold capillaries in ASCT patients. For Autologous Stem Cell Transplant (ASCT) participants, the imaging will be performed once prior to ASCT upon admission to the hospital, and then daily after ASCT (starting on day +7) until count recovery
Primary Outcome Measures
NameTimeMethod
Video of nail-fold imaging captured by capillaroscope4 weeks

Image acquisition from device to then analyze and compare with complete blood counts measured in a standard fashion

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath